Previous Close | 3.0500 |
Open | 3.0800 |
Bid | 3.0100 x 700 |
Ask | 3.0600 x 200 |
Day's Range | 3.0100 - 3.1850 |
52 Week Range | 2.7600 - 12.3600 |
Volume | |
Avg. Volume | 809,109 |
Market Cap | 678.49M |
Beta (5Y Monthly) | 2.53 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.5900 |
Earnings Date | Apr 23, 2024 - Apr 29, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 13.25 |
Subscribe to Yahoo Finance Plus to view Fair Value for CVAC
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
CureVac N.V. (CVAC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
The heavy selling pressure might have exhausted for CureVac N.V. (CVAC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.